Breast cancer screening overdiagnosis risk may have been overestimated for decades

A new analysis reexamined all eight major randomized breast cancer screening trials and adjusted for follow-up time, screening frequency, and screening after trials ended. It found mammogram overdiagnosis consistent with a rate below 5%, not the roughly 30% to 50% suggested by some earlier estimates.